Survival Benefit of Deceased Donor Kidney Transplantation among Patients with Peripheral Artery Disease
Annals of Vascular Surgery · 2026
DOI: 10.1016/j.avsg.2025.07.010 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Vascular Surgery, 2026. Verfasst von Li Ting Tan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: ltan18@jh.edu. Hauptthemen laut MEDLINE: Kidney Transplantation, Peripheral Arterial Disease, Waiting Lists, Kidney Failure, Chronic. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Institutes of Health, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
BACKGROUND: Peripheral artery disease (PAD) is a common comorbidity among patients waitlisted for deceased donor kidney transplant (DDKT). However, some centers consider PAD a contraindication for transplant given the higher risk of postoperative complications. We aimed to examine the survival benefit of DDKT among patients with and without PAD. METHODS: We used data from the Scientific Registry of Transplant Recipients (SRTR) from January 2003 to December 2022 to identify all DDKT waitlist candidates. Kaplan-Meier survival estimates and multivariable Cox proportional hazards models were used to compare patient mortality for those who received a DDKT versus those remaining on the waitlist, stratified by PAD status. RESULTS: Overall, 506,785 candidates were listed for adult kidney-only transplant during the study period, of which 8.7% had PAD and 36.0% received a DDKT. After a median follow-up time of 3.21 years from waitlist activation [interquartile range 1.11-7.03 years], mortality varied significantly according to DDKT and PAD status. After adjusting for baseline differences, DDKT was associated with a significantly lower hazard of death compared to remaining on the waitlist, regardless of PAD status [adjusted hazards ratio 0.45-0.60, P < 0.001]. Further stratifying by sex, race and ethnicity, and diabetes status did not substantially alter these results. CONCLUSION: PAD includes a spectrum of diseases with varying mortality risks. As captured and dichotomized in the SRTR database, DDKT conferred a similar long-term benefit relative to remaining on the waitlist for candidates with and without PAD. Therefore, PAD should not be an absolute contraindication to DDKT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: ltan18@jh.edu.
- Department of Surgery, Brigham and Women's Hospital, Boston, MA.
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
- Department of Surgery, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, MD.
- Department of Surgery, NYU Grossman School of Medicine, New York, NY.
Förderung
- National Institutes of Health
- National Heart, Lung, and Blood Institute
Zitieren
APA
Tan, L. T., Kernodle, A. B., Yu, S., McDermott, K., White, M., Holscher, C. M., Lum, Y. W., Segev, D. L., Massie, A. B., King, E. A., Black, J. H., & Hicks, C. W. (2026). Survival Benefit of Deceased Donor Kidney Transplantation among Patients with Peripheral Artery Disease. Annals of Vascular Surgery. https://doi.org/10.1016/j.avsg.2025.07.010
Vancouver
Tan LT, Kernodle AB, Yu S, McDermott K, White M, Holscher CM, et al. Survival Benefit of Deceased Donor Kidney Transplantation among Patients with Peripheral Artery Disease. Annals of Vascular Surgery. 2026. doi:10.1016/j.avsg.2025.07.010
BibTeX
@article{Tan2026,
author = {Tan, Li Ting and Kernodle, Amber B and Yu, Sile and McDermott, Katherine and White, Midori and Holscher, Courtenay M and Lum, Ying Wei and Segev, Dorry L and Massie, Allan B and King, Elizabeth A and Black, James H and Hicks, Caitlin W},
title = {Survival Benefit of Deceased Donor Kidney Transplantation among Patients with Peripheral Artery Disease},
journal = {Annals of Vascular Surgery},
year = {2026},
doi = {10.1016/j.avsg.2025.07.010}
}
EUVIMED